Document is current
Any future updates will be listed below
-
Authors
Wedegärtner, Sonja Maria
Böhm, Michael
Bernhard, Benedikt
Schwantke, Igor
Kindermann, Ingrid
Karbach, Julia https://orcid.org/0000-0003-2763-6351
-
Funding
Funding for this research was provided by:
Deutsche Stiftung für Herzforschung (F/53/13, F/53/13)
Rheinland-Pfälzische Technische Universität Kaiserslautern-Landau
- License Information
-
More Information
Article History
Received: 6 October 2024
Accepted: 22 April 2025
First Online: 9 May 2025
Declarations
:
: Sonja Wedegärtner reports personal fees from Servier Deutschland GmbH. Michael Böhm reports personal fees from Abbott, Astra-Zeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Medtronic, Novartis, Servier, and Vifor. Ingrid Kindermann reports personal fees from Akcea Therapeutics Germany GmbH, AstraZeneca, Alnylam, Bayer Vital GmbH, Boehringer Ingelheim, Bristol-Myers-Squibb Company, Daiichi Sankyo Deutschland, Hexal AG, Novartis, Pfizer Pharma GmbH, Servier Deutschland GmbH, and Vifor.
